[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363153-105":59,"doc-detail-363153-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","bioinformatics-analysis-of-micrornas-associated-with-metastatic-potential-in-breast-cancer","Bioinformatics Analysis of microRNAs Associated with Metastatic Potential in Breast Cancer","","Dysregulation of microRNA expression in breast cancer (BC) contributes to molecular changes driving cancer initiation, progression, and metastasis. This work applies bioinformatics to identify and characterize microRNAs that may regulate epithelial–mesenchymal transition, migration, invasion, and hormonal signaling. Data from three BC cell-line profiling studies and an additional study of lymph node metastases with matched primary tumors were integrated to obtain five differential microRNAs, then assessed for clinical relevance and validated in BC cell lines using target prediction, network construction, functional enrichment, and qPCR.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinformatics-analysis-of-micrornas-associated-with-metastatic-potential-in-breast-cancer/363153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinformatics-analysis-of-micrornas-associated-with-metastatic-potential-in-breast-cancer/363153.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the goal of the study?","Question",{"text":113,"@type":114},"To use bioinformatics to identify candidate microRNAs associated with metastatic potential in breast cancer and characterize their functional properties.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the microRNAs identified?",{"text":118,"@type":114},"By integrating microRNA profiling data from three BC cell-line studies with different invasive capabilities and from a study involving lymph node metastases and matched primary tumors.",{"name":120,"@type":111,"acceptedAnswer":121},"Which microRNA showed distinctive pro-metastatic properties?",{"text":122,"@type":114},"miR-222-3p, which was upregulated and supported by clinical relevance and functional enrichment of its target genes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363153,1790526578,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nBioinformatics Analysis of microRNAs Associated with Metastatic Potential in Breast Cancer  \nAleksandra Nikezi´c 1, Sanja Goˇc 2, Jovana Stevanovi´c 2, Miloš Brkušanin 3, Olgica Nedi´c 2, Jovana Jovanki´c 1 and Zorana Dobrijevi´c 2, *  \nAcademic Editor: Yuan Zhou  \nReceived: 12 March 2026  \nRevised: 30 March 2026  \nAccepted: 9 April 2026  \nPublished: 14 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia; [aleksandra.nikezic@pmf.kg.ac.rs](aleksandra.nikezic@pmf.kg.ac.rs) (A.N.); [jovana.jovankic@pmf.kg.ac.rs](jovana.jovankic@pmf.kg.ac.rs) (J.J.)  \n2 Institute for the Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia; [sanjagoc@inep.co.rs](sanjagoc@inep.co.rs) (S.G.); [jovana.stevanovic@inep.co.rs](jovana.stevanovic@inep.co.rs) (J.S.); [olgica@inep.co.rs](olgica@inep.co.rs) (O.N.)  \n3 Centre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11158 Belgrade, Serbia; [milosb@bio.bg.ac.rs](milosb@bio.bg.ac.rs)  \n* Correspondence: [zorana.dobrijevic@inep.co.rs](zorana.dobrijevic@inep.co.rs)  \nSimple Summary  \nKey microRNA players that are relevant for breast cancer aggressiveness, with crucial roles in mediating cancer migration, epithelial–mesenchymal transition, invasion and metastasis, remain underexplored. Therefore, we aimed to address this issue and uncover the potential candidate microRNAs associated with the metastatic potential of breast cancer by employing an in silico approach. We combined data from microRNA profiling studies to identify a minimal set of dysregulated microRNAs and to bioinformatically characterize their potential functional properties. Five microRNAs emerged as plausible cancer aggressiveness-associated regulators, one of which displayed distinctive pro-metastatic properties, while three downregulated microRNAs were significantly associated with negative clinical features, and their targets were enriched with genes that were relevant for cancer’s aggressiveness. These results are consistent with the presumed functional relevance of selected DE-microRNAs in BC and hold their value for future investigations focusing on biomarker discovery, improvements in diagnosis, outcome prediction, decisionmaking and treatment monitoring, as well as for enhancing therapeutic effectiveness.  \nAbstract  \nDysregulation of microRNA expression in breast cancer (BC) has been associated with molecular disturbances involved in cancer initiation, progression and metastasis. Specific microRNAs also act as endocrine modulators in BC, thereby influencing the biological behavior of the tumor and drug responses. Our objective was to employ bioinformatics tools to identify and characterize microRNAs acting as candidate players involved in epithelial– mesenchymal transition, migration, invasion, and/or hormonal regulation in BC. We systematically integrated microRNA profiling data from three different studies on BC cell lines with different invasive capabilities and from another study on lymph node metastases and matching primary BC, resulting in five microRNA hits—DE-microRNAs miR-146a-5p, miR-222-3p, miR-205-5p, miR-141-3p and miR-200c-3p. This set of microRNAs was evaluated for clinical significance in BC and subjected to target prediction, microRNA–mRNA network construction, functional enrichment analysis and quantification in BC cell lines by qPCR. An upregulated DE-microRNA, miR-222-3p, displayed distinctive pro-metastatic features, supported by its clinical relevance, as well as by the results of the functional enrichment analysis of its target genes. Downregulation of the members of the miR-200 family and miR-205-5p were significantly associated with negative clinical features, while  \ntheir targe","cbCaiubuSG0JPDRg","https://ap.wps.com/l/cbCaiubuSG0JPDRg","pdf",7392127,27,"English","# Introduction\n## Breast cancer burden and clinical aggressiveness\n## Motivation and research objective\n# Methods and integrated analysis","[{\"question\":\"What was the goal of the study?\",\"answer\":\"To use bioinformatics to identify candidate microRNAs associated with metastatic potential in breast cancer and characterize their functional properties.\"},{\"question\":\"How were the microRNAs identified?\",\"answer\":\"By integrating microRNA profiling data from three BC cell-line studies with different invasive capabilities and from a study involving lymph node metastases and matched primary tumors.\"},{\"question\":\"Which microRNA showed distinctive pro-metastatic properties?\",\"answer\":\"miR-222-3p, which was upregulated and supported by clinical relevance and functional enrichment of its target genes.\"}]","Bioinformatics Analysis of microRNAs Associated with Metastatic Potential in Breast Cancer | PDF",1790150203,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a74df57891ed67b3dece04f958ba1a51.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86982ef200aedd9e9a5ad558462b6109.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc90bacce7339cef0d4df69380595f22.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43772138808185700ddb28e9acc06dc4.webp",980,1385]